Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 34, 2023 - Issue 1
Submit an article Journal homepage
2,659
Views
1
CrossRef citations to date
0
Altmetric
Editorial

Drug tolerability versus drug safety

Stuti Prajapatia Department of Dermatology, Center for Dermatology Research, Wake Forest University School of Medicine, Winston-Salem, NC, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0009-0006-9889-5325View further author information
ORCID Icon,
Rachel Taoa Department of Dermatology, Center for Dermatology Research, Wake Forest University School of Medicine, Winston-Salem, NC, USAView further author information
&
Steven R. Feldmana Department of Dermatology, Center for Dermatology Research, Wake Forest University School of Medicine, Winston-Salem, NC, USA;b Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, NC, USA;c Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, NC, USA;d Department of Social Sciences & Health Policy, Wake Forest University School of Medicine, Winston-Salem, NC, USAView further author information
Article: 2202786 | Received 09 Apr 2023, Accepted 10 Apr 2023, Published online: 27 Apr 2023
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
"Drug tolerability versus drug safety." Journal of Dermatological Treatment, 34(1), pp.

Disclosure statement

He is founder and part owner of Causa Research and holds stock in Sensal Health. Prajapati and Tao have no conflicts to disclose. No potential conflict of interest was reported by the author(s).

Additional information

Funding

Feldman has received research, speaking and/or consulting support from Eli Lilly and Company, GlaxoSmithKline/Stiefel, AbbVie, Janssen, Alovtech, vTv Therapeutics, Bristol-Myers Squibb, Samsung, Pfizer, Boehringer Ingelheim, Amgen, Dermavant, Arcutis, Novartis, Novan, UCB, Helsinn, Sun Pharma, Almirall, Galderma, Leo Pharma, Mylan, Celgene, Ortho Dermatology, Menlo, Merck & Co, Qurient, Forte, Arena, Biocon, Accordant, Argenx, Sanofi, Regeneron, the National Biological Corporation, Caremark, Teladoc, BMS, Ono, Micreos, Eurofins, Informa, UpToDate and the National Psoriasis Foundation.
Download PDF

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.